Research Insights
In-depth articles on peptide science, analytical methodology, and emerging trends in biomedical research.
NewsInside the European Peptide & Analytics Gateway Summit 2026
Myotrope joined leading researchers, manufacturers, and analytical chemists at EPAG Summit 2026 in Amsterdam — a three-day event redefining how the peptide research community shares quality data and builds scientific trust.
Clinical StudyPeptide Efficacy in Metabolic Health: Gender-Specific Findings
An analysis of peptide interactions across dimorphic metabolic pathways, highlighting variations in cellular uptake and receptor affinity between gender cohorts.
TrendsEmerging Trends in Longevity Research: Senolytics & NAD+ Precursors
Evaluating the next generation of senolytic compounds and their potential to modulate NAD+ precursors for enhanced mitochondrial resilience.
MethodologyOptimizing HPLC Protocols for High-Purity Peptide Synthesis
Technical review of reverse-phase chromatography techniques used to achieve purity levels exceeding 99% in large-scale peptide production.
Clinical StudyThe Role of BPC-157 in Tissue Repair: A Research Overview
Comprehensive review of BPC-157 research findings, examining its reported effects on tissue repair mechanisms, angiogenesis, and the nitric oxide system.
MethodologyPeptide stacking: a guide to multi-compound research protocols
Why researchers combine peptides into stacks, how synergistic pathways work, and practical guidelines for designing multi-compound protocols — from the classic BPC-157 + TB-500 to growth hormone and cognitive stacks.
Clinical StudyPeptides for men vs. women: how biology shapes research outcomes
Sex-specific differences in receptor density, hormone interactions, and pharmacokinetics mean that peptide research outcomes can differ significantly between male and female models. Here's what the literature shows.
Clinical StudyWhat is Semaglutide? Mechanism, effects, and research findings
Semaglutide is the most researched GLP-1 receptor agonist in the world. This article breaks down how it works, what preclinical and clinical studies have found, and why it has become central to metabolic and obesity research.
Clinical StudyTB-500 explained: Thymosin Beta-4, tissue repair, and recovery research
TB-500 is a synthetic version of Thymosin Beta-4, one of the most abundant and versatile peptides in the body. This article covers its mechanisms, what preclinical studies have found across musculoskeletal and cardiovascular tissues, and how it differs from BPC-157.
Clinical StudyGHK-Cu: the science behind copper peptides for skin and hair research
GHK-Cu is a naturally occurring copper peptide with a remarkable range of biological activities — from collagen synthesis and wound repair to antioxidant defence and hair follicle activation. Here's what the research literature shows.
Clinical StudyCJC-1295 + Ipamorelin: understanding the GH-releasing peptide stack
CJC-1295 and Ipamorelin are the most studied GH-releasing peptide combination in preclinical research. This article explains how each works, why they are used together, and what the data shows across ageing, body composition, and recovery models.
TrendsSelank and Semax: cognitive peptides and neuroprotection research
Developed in Russia and studied extensively in Eastern European research institutions, Selank and Semax are among the most investigated cognitive peptides in preclinical literature. This overview examines their mechanisms, what the data shows, and how they differ.